Through a retrospective examination of reported instances of cancer-related hypoglycemia, Scalia et al. [18] and his team discovered that the vast majority (95%, or 171 cases out of 180) of the associated IGF was attributed to secreted IGF-II. This evidence concerns the gene IGF2 and cancer.